Pitfalls in the Diagnosis of Multiple Sclerosis
Gradually Progressive Myelopathy
Release Date: December 7, 2018
Expiration Date: December 7, 2020
Estimated Time of Completion: 1 hour
Description
The signs and symptoms associated with multiple sclerosis, the varied aspects of disease progression, lack of specific biomarkers, and difficult-to-interpret imaging results often lead to diagnostic errors, both misdiagnosis and underdiagnosis. With MS, these errors can lead to unnecessary and potentially harmful risks to patients from treatment strategies that are based on incorrect diagnoses. Pitfalls in the Diagnosis of Multiple Sclerosis Case-Based Series will discuss the criteria for diagnosis and review of guidelines to improve diagnosis rates ultimately, improving patient care.
This case will review progressive myelopathy.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated that he has no relationship which, in the context of his presentation, could be perceived as a potential conflict of interest:
Alexander D. Rae-Grant, MD
All other planners, CME staff, and content reviewers, have no relevant financial relationships to disclose
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges
educational grants for partial support of this activity from:
Abbvie, Inc.
Biogen
Sanofi Genzyme
This CME activity was produced by Cleveland Clinic
Center for Continuing Education and
Cleveland Clinic's Mellen Center for Neurology Treatment and Research.